NeoModafinil - About the company
NeoModafinil is an unfunded company based in United Kingdom, founded in 2017. It operates as a Retailer of generic modafinil and armodafinil products from Indian manufacturers. NeoModafinil has not raised any funding yet. The company has 415 active competitors, including 8 funded and 33 that have exited. Its top competitors include companies like Pfizer, SK bioscience and Combitic Global Caplet.
Company Details
Retailer of generic modafinil and armodafinil products from Indian manufacturers. The company offers various brands of modafinil and armodafinil. Orders are shipped via express mail service or registered airmail. A refund or reshipment is offered if orders are delayed beyond a specified timeframe. Payments are accepted via credit card and Bitcoin.
Key Metrics
Sign up to download NeoModafinil's company profile
NeoModafinil's funding and investors
NeoModafinil has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
NeoModafinil's Competitors and alternates
Top competitors of NeoModafinil include Pfizer, SK bioscience and Combitic Global Caplet. Here is the list of Top 10 competitors of NeoModafinil, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Pfizer 1849, New York City (United States), Public | Provider of pharmaceutical products for multiple disease treatments | - | 67/100 | |
2nd |  SK bioscience 2018, Seongnam-si (South Korea), Public | Developer of vaccines for infectious diseases and recombinant protein therapeutics | - | 49/100 | |
3rd | Combitic Global Caplet 1981, Delhi (India), Unfunded | Developer of didactic learning systems for vocational training | - | - | 47/100 |
4th |  Cost Plus Drug 2016, Dallas (United States), Unfunded | Distributor of generic drugs | - | - | 46/100 |
5th |  Lovell Government Services 2013, Pensacola (United States), Unfunded | Distributor of pharmaceutical products | - | - | 43/100 |
6th |  PillSorted 2019, Cambridge (United Kingdom), Seed | Distributor of drugs | $6M | 41/100 | |
7th | Provider of re-imported pharmaceuticals and parallel imported medicines for pharmacies | - | - | 40/100 | |
8th | Aurobindo Pharma USA 1994, East Windsor (United States), Unfunded | Distributor of generic drugs | - | - | 38/100 |
9th |  Getz Healthcare 1905, Lane Cove (Australia), Unfunded | Distributor of generic drugs and medical devices | - | - | 38/100 |
10th |  Uth Healthcare 2011, Pune (India), Acquired | Distributor of diabetes, obesity, and other drugs | - | - | 38/100 |
415th |  NeoModafinil 2017, United Kingdom, Unfunded | Retailer of generic modafinil and armodafinil products from Indian manufacturers | - | - | 16/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on NeoModafinil's competitors? Click here to see the top ones
NeoModafinil's Investments and acquisitions
NeoModafinil has made no investments or acquisitions yet.
Reports related to NeoModafinil
Here is the latest report on NeoModafinil's sector:
Are you a Founder ?
FAQs about NeoModafinil
Explore our recently published companies
- AI Volu - Unfunded company
- Alliancedentalsolutions - Unfunded company
- DEON Studios - Cordoba based, 2017 founded, Unfunded company
- Oath Biome - San Francisco based, 2022 founded, Funding Raised company
- Merit Builders - Caloundra based, Unfunded company
- iGreen - Hungary based, 2023 founded, Unfunded company
